Atlas Trials

PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

Clinical trial NCT06616532 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06616532
Sponsor
Biotheus Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
SCLC
Start date
2024-11-13
Primary completion
2027-01-25
Enrollment
404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.